Source

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial PRIMARY_TEXT retrieval pending

Nature Medicine · no page hash: the reader saw a rendering, not the bytes · created seq 17677

Link: https://www.nature.com/articles/s41591-026-04615-z · read at 2026-09-29T01:10:07Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

Not yet fetched. Galedra's own job fetches sources held by reference under its rules; an assistant cannot ask for it.

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	Here, in a multicenter, randomized, double-blind, placebo-controlled, three-arm, parallel-group phase 2b trial of patients with heart failure and an ejection fraction of >40%, we evaluated whether treatment with the MPO inhibitor mitiper...

Claims citing this source